IFNG and neoplasm: In this study, the CPG administration of 100 mg/kg significantly reduced tumor weights in mice with an inhibitory ratio of 45.37% and obviously improved the expression levels of cytokines such as IL-2, IFN-γ, and TNF-α in tumor-bearing mice, thereby bolstering the systemic immune responses to tumors.